We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 59

Ranbaxy loses FDA approval for two generics
  • Shook Hardy & Bacon LLP
  • USA, India
  • November 13 2014

According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA


Fake cosmetics-manufacturing facilities sealed in Bangladesh; truckloads of goods destroyed
  • Shook Hardy & Bacon LLP
  • India, USA
  • July 10 2014

According to news sources, a mobile court that is part of a Rapid Action Battalion in Bangladesh recently conducted a raid that resulted in the


Cosmetics, personal care products purportedly linked to kids’ allergies
  • Shook Hardy & Bacon LLP
  • India
  • November 20 2014

A small study of households in India has purportedly associated higher levels of indoor pollutants, including household products, such as cosmetics


Most ad complaints involving personalhealth care products upheld in India
  • Shook Hardy & Bacon LLP
  • India
  • July 10 2014

The most recent data released by the Advertising Standard Council of India (ASCI) show that the largest percentage of complaints upheld (95--46


Indian Supreme Court rules Novartis cancer drug change not patentable
  • Shook Hardy & Bacon LLP
  • India
  • April 4 2013

The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also


UK and India to fund genomics and bioinformatics tech research
  • Shook Hardy & Bacon LLP
  • United Kingdom, India
  • April 4 2013

According to the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC), up to £10 million has been jointly pledged by the council and


India to ban PET packaging for certain pharmaceuticals
  • Shook Hardy & Bacon LLP
  • India, USA
  • January 9 2014

Citing increasing concerns about potential adverse health effects, the Indian Health Ministry is reportedly considering prohibiting the use of


State body opposes India drugs and cosmetics bill, 2013
  • Shook Hardy & Bacon LLP
  • India
  • October 31 2013

According to news sources, the All India Drug Control Officers' Confederation (AIDCOC) has raised objections to proposed amendments to India's Drug


Drug companies and policymakers watch patent dispute before India’s high court
  • Shook Hardy & Bacon LLP
  • India
  • March 15 2012

According to a news source, the India Supreme Court will hear final arguments in March 2012 on whether the manufacturer of a drug that could not be patented in India because it was created before 1995 during a moratorium on the grant of patents to Western companies, may obtain a patent in that country for a newer form of the drug


Drug makers complain about slow regulatory approvals in India
  • Shook Hardy & Bacon LLP
  • Global, India
  • February 21 2013

Pharmaceutical companies have reportedly begun shifting their clinical trials out of India, claiming that bureaucrats have been slow to approve them